SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-044463
Filing Date
2022-04-11
Accepted
2022-04-11 08:00:26
Documents
8
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm223451d1_pre14a.htm PRE 14A 1302284
2 GRAPHIC tm223451d1_pre14asp1img001.jpg GRAPHIC 22685
3 GRAPHIC tm223451d1_pre14asp3img004.jpg GRAPHIC 24891
4 GRAPHIC tm223451d1_pre14asp3img005.jpg GRAPHIC 11239
5 GRAPHIC tm223451d1_pre14asp5img001.jpg GRAPHIC 128861
6 GRAPHIC tm223451d1_pre14asp3img006.jpg GRAPHIC 24824
7 GRAPHIC tm223451d1_pre14aimg001.jpg GRAPHIC 597486
8 GRAPHIC tm223451d1_pre14aimg002.jpg GRAPHIC 433063
  Complete submission text file 0001104659-22-044463.txt   3016727
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37368 | Film No.: 22818504
SIC: 2836 Biological Products, (No Diagnostic Substances)